Dr. Holmes on Neoadjuvant Endocrine Therapy in Breast Cancer

Frankie Ann Holmes, MD
Published: Friday, Sep 01, 2017



Frankie Ann Holmes, MD, a physician at Texas Oncology, discusses neoadjuvant endocrine therapy for patients with breast cancer.

There will always be patients who do not choose to receive chemotherapy for tumors that are too large to remove by surgery, states Holmes. Some fast-growing tumors in select breast cancer subtypes may respond to deprivation of estrogen more than chemotherapy, explains Holmes.

SELECTED
LANGUAGE


Frankie Ann Holmes, MD, a physician at Texas Oncology, discusses neoadjuvant endocrine therapy for patients with breast cancer.

There will always be patients who do not choose to receive chemotherapy for tumors that are too large to remove by surgery, states Holmes. Some fast-growing tumors in select breast cancer subtypes may respond to deprivation of estrogen more than chemotherapy, explains Holmes.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Community Practice Connections™: Evolving Applications for PARP Inhibitors in Ovarian Cancer: Building on a Solid FoundationAug 15, 20191.5
Publication Bottom Border
Border Publication
x